Profiles >> Cheyne Capital Management LLP >> 13Fs >> 2015-06-30
Cheyne Capital Management LLP
Last Updated: 3/2/2021
Cheyne Capital Management LLP is a Limited Liability Partnership that started in 2000 and is primarily owned and controlled by Jonathan Lourie. To see a profile of the company, click here.
Below is the 13F Filing for Cheyne Capital Management LLP for Report Period 2015-06-30. Historical analysis on the top 100 Holdings are available by clicking on the Issuer Name in the list.
Historical 13F Holdings - 2015-06-30
Loading, please wait
Issuer | Title of Class | CUSIP | Value(1000s) | Share | SH/PRN | Put/Call | Investment Discretion | Other Manager | Sole | Shared | None |
---|---|---|---|---|---|---|---|---|---|---|---|
ACORDA THERAPEUTICS INC | NOTE 1.750% 6/1 | 00484MAA4 | 2022 | 2000000 | PRN | SOLE | 2000000 | 0 | 0 | ||
AIR PRODS & CHEMS INC | COM | 009158106 | 1847 | 13500 | SH | SOLE | 13500 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 336 | 73000 | SH | SOLE | 73000 | 0 | 0 | ||
ALTERA CORP | COM | 021441100 | 21016 | 410585 | SH | SOLE | 410585 | 0 | 0 | ||
AMERCO | COM | 023586100 | 694 | 2120 | SH | SOLE | 2120 | 0 | 0 | ||
AMERICAN AIRLS GROUP INC | COM | 02376R102 | 499 | 12500 | SH | SOLE | 12500 | 0 | 0 | ||
APPLIED MATLS INC | COM | 038222105 | 2017 | 105000 | SH | SOLE | 105000 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 274 | 90000 | SH | SOLE | 90000 | 0 | 0 | ||
BABSON CAP GLB SHT DURHGH YL | COM | 05617T100 | 291 | 500000 | SH | SOLE | 500000 | 0 | 0 | ||
BARRICK GOLD CORP | COM | 067901108 | 534 | 50000 | SH | SOLE | 50000 | 0 | 0 |